Maternal serum lactate dehydrogenase level and adverse pregnancy outcomes in women with hypertensive disorder of pregnancy at a tertiary care centre: a retrospective study

Disha Ajila, Aishwarya Raja, Pradeep Ganiga


Background: Hypertensive disorder of pregnancy affect 6-8% of all pregnancies, contributing immensely to maternal morbidity and mortality. Thus, presence of lactate dehydrogenase (LDH) signifies tissue damage and haemolysis. The aim of the study was to correlate LDH levels with blood pressure ranges and maternal and foetal outcome in women with gestational hypertension, pre-eclampsia.

Methods: This retrospective study was conducted in the department of obstetrics and gynaecology of AJ Institute of Medical Sciences and Research Centre, Mangalore for a period of 1 year (January 2020 to January 2021). Based on the eligibility criteria, 52 hypertensive pregnant women were enrolled as cases.

Results: Mean±SD period of gestation at delivery was lowest (34.57±1.39 weeks) for pregnant women with S. LDH levels>800 IU/l, whereas with S. LDH<00 IU/l delivered at around 37 weeks of gestation. Mean Apgar scores were lowest for the babies born to hypertensive pregnant women>800 IU/l, mean±SD Apgar scores at the end of 1 min, 5 minutes and 10 min were 4.42±0.79, 4.75±2.26 and 5.50±2.65 respectively.

Conclusions: It can be concluded that S. LDH has the potential to be considered as a screening tool or predictor of the outcome of pregnancy in women with hypertensive disorders of pregnancy. However, studies of larger magnitude may be required to confirm the presence and the strength of association of S. LDH levels with pregnancy outcome.


Lactic, Dehydrogenase, Preeclampsia, Eclampsia, Maternal outcome

Full Text:



National Health Portal of India. Preeclampsia, 2021. Available at:,the%20study%20population%20in%20India. Accessed on 01 December 2021.

ACOG Practice Bulletin Summary. Gestational Hypertension and Preeclampsia, Number 222. Obstet Gynecol. 2020;135(6):1492-5.

Duley L. Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean. Br J Obstet Gynaecol. 1999;99(7):547-53.

WHO. Trends in maternal mortality: 1990 to 2010. Geneva: WHO; 2012.

Dharmashankar K, Widlansky ME. Vascular endothelial function and hypertension: insights and directions. Curr Hypertens Rep. 2010;12(6):448-55.

Kant RH, Mir N, Sarwar S, Gupta S, Najeeb R. Role of maternal serum lactate dehydrogenase as a biochemical marker in pre-eclampsia. IOSR J Dental Med Sci. 2015;14(7):12-9.

Jain S, Pinto B, Kalra N, Dhawan V. Relationship Between Inflammation and Endothelial Dysfunction in Essential Hypertension. J Hypertension. 2015;33(2):4.

Butt AA, Michaels S, Greer D, Clark R, Kissinger P, Martin DH. Serum LDH level as a clue to the diagnosis of histoplasmosis. AIDS Read. 2002;12(7):317-21.

NICE. Overview- Hypertension in pregnancy: diagnosis and management, 2019. Available at: Accessed on 01 December 2021.

Dave A, Maru L, Jain A. LDH (Lactate Dehydrogenase): A Biochemical Marker for the Prediction of Adverse Outcomes in Pre-eclampsia and Eclampsia. J Obstet Gynaecol India. 2016;66(1):23-9.

Kharb S, Bhandari N, Gupta S. Lactate dehydrogenase and maternal and perinatal outcome in preeclamptic women. Archives Med Health Sci. 2019;7(2):163.

Mehta M, Parashar M, Kumar R. A Serum LDH: a prognostic factor in pre-eclampsia. Int J Reprod Contracept Obstet Gynecol 2019;8:2792-8.

Hak J, Nisa N, Gupta S. LDH Levels in Pregnancy and its Association with Severity of the Disease and Feto-maternal Outcome in Pre-eclampsia and Eclampsia. J Med Educ Res. 2015;17(3):110-3.

Murthy KD, Siddiqui D. To study the correlation of serum lactate dehydrogenase (LDH) levels in women with preeclampsia on maternal and perinatal outcome. Obsgyne Review: J Obstet Gynecol. 2019;5(1):19-25.

Bairwa R, Iqbal S. Serum lactate dehydrogenase (LDH) level in mild and severe preeclampsia as a prognostic marker. Int J Reprod Contracept Obstet Gynecol. 2018;7:3969-74.